Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerating Cognition-guided Signatures to Enhance Translation in Depression Aim 3: Clinical Cognitive Trial

NCT06408246 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06408246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerating Cognition-guided Signatures to Enhance Translation in Depression Aim 3: Clinical Cognitive Trial
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Recruiting
Start date
March 3, 2026
Completion date
February 1, 2029
Enrollment
162 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression